ArticleFrontiers in endocrinology2025
Case report: Takotsubo cardiomyopathy and cardiac arrest in a 9-year-old girl with new-onset diabetes presenting with diabetic ketoacidosis: the chicken or the egg?
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic ketoacidosis (DKA) is an acute and life-threatening complication of diabetes mellitus type 1 (T1DM). There is no published data about the incidence of cardiac arrest in pediatric DKA, but the scarcity of published case reports suggests a very low incidence. Here we present a rare case of a previously healthy 9-year-old girl with new T1DM presenting with severe DKA and influenza infection who developed cardiac arrest, ventricular tachycardia (VT) and stress cardiomyopathy during the initial hours of DKA treatment without any underlying electrolyte disorder, heart disease or hypoglycemia. Case report: A 9-year-old febrile girl was admitted to our pediatric intensive care unit (PICU) for treatment of severe DKA (pH 6.72, bicarbonate 3.4 mmol/L, glycaemia 28.2 mmol/L, urine ketones 10 mmol/L) with normal electrolyte status. The treatment of severe DKA was promptly started, with the addition of mannitol due to computed tomography (CT) signs of mild initial cerebral swelling. In the seventh hour of DKA treatment, bradycardia developed and, within a minute, progressed to asystolic cardiac arrest with a resultant sudden drop in oxygen saturation and arterial pressure. Immediate measures of cardiopulmonary-cerebral resuscitation were started, and adrenaline and atropine were administered, which resulted in a change from asystole to polymorphic ventricular tachycardia. Two direct current cardioversions were performed, restoring the patient's sinus rhythm and stabilization. Blood gas analyses showed the persistence of hyperglycemia and severe metabolic acidosis (pH 6.81, HCO3 4.0 mmol/L, glycemia 34.8 mmol/L) without any electrolyte imbalances and further increase in lactate levels. The girl was intubated, and mechanical ventilation was initiated. Echocardiography detected moderately impaired left ventricular systolic function, hypo- and dyskinesia of the interventricular septum. Bicarbonates and inotropic stimulation were administered. The further clinical course was uneventful, with gradual improvement, resolution of ketoacidosis, and restoration of cardiac function. Due to a mild fever and elevated C-reactive protein levels, a PCR test confirmed an infection with the AH3+ influenza virus. She was discharged after 14 days of treatment with insulin and an ACE inhibitor, with normal echocardiography findings. Conclusion: This case highlights that potentially fatal stress cardiomyopathy and cardiac arrest can unexpectedly occur during the treatment of pediatric severe DKA, even without electrolyte disturbances, brain edema or any history of prior heart disease. Due to these risks, we conclude that all pediatric patients with severe DKA should be treated in the PICU, with continuous ECG monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.